Medicare Pilot Program Offers GLP-1 Discounts, Excludes Certain Patients

Why it matters locally: Texas, with its large senior population, will see many residents potentially affected by Medicare's new pilot program for GLP-1 medications. While some Texans may benefit from reduced costs, the program's exclusion of individuals with severe illnesses means many others will continue to face high out-of-pocket expenses for these drugs.

---

Medicare has introduced a pilot program aimed at streamlining access to GLP-1 medications. Under this initiative, some seniors pay $50 per month for these drugs. However, the program's structure means that many individuals with severe illnesses do not qualify for this reduced rate. Jeff La Marca, for example, received a prescription for the weight-loss drug Zepbound in January. He faced a monthly cost of $750 for the medication.